The relationship between nutritional status and the glasgow prognostic score in patients with cancer of the esophagus and stomach

Nutrition and Cancer

Volumn 65, Issue 1, 2013, Pages 25-33

  Da Silva, Jacqueline Braga ^a,b   Maurício, Sílvia Fernandes ^a   Bering, Tatiana ^a   Correia, Maria Isabel T D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital of Clinics ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARM CIRCUMFERENCE; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DISEASE SEVERITY; ESOPHAGUS CANCER; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GLASGOW PROGNOSTIC SCORE; GRIP STRENGTH; HUMAN; INFECTION COMPLICATION; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MUSCLE THICKNESS; NAUSEA AND VOMITING; NUTRITIONAL ASSESSMENT; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; SKINFOLD; STOMACH CANCER; SUBJECTIVE GLOBAL ASSESSMENT; SURVIVAL TIME;

EID: 84873725115     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.741755     Document Type: Article

References (24)

1. World Health Organization: World Cancer Report, 2008. International Agency for Research on Cancer, Lyon, France, 2009.
2. Mcmillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12, 223-226, 2009.
3. Slaviero KA, Clarke SJ, Mclachlana J, Blair EY, and Rivory LP: Population pharmacokinetics of weekly docetaxel in patients with advanced cancer. Brit J Clin Pharmacology 57, 44-53, 2004.
4. Andreyev HJN, Norman AR, Oates J, and Cunninghan D:Why do patients with weight have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503-509, 1998.
5. Colasanto JM, Prasad P, Nash MA, Decker RH, and Wilson LD: Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology 19, 371-379, 2005.
6. Gupta D, Lis CG, Dahlk SL, King J, Vashi PG: The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J 7, 19, 2008.
7. Barbosa-Silva MC and Barros AJD: Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 8, 311-317, 2005.
8. Schlüssel MM, Anjos LA, and Kac G: A dinamometria manual e seu uso na avaliação nutricional. Revista de Nutrição 22, 223-235, 2008.
9. National Cancer Institute: Division of Cancer Treatment and Diagnosis. Common toxicity criteria, Version 3.0. National Cancer Institute, 2006.
10. Frisancho AR: Anthropometric Standards for the Assessment of Growth and Nutritional Status. The University of Michigan Press, Ann Arbor, 1990, pp. 48-53.
11. Frisancho AR: Newnorms of upper limb fat andmuscle areas for assessment of nutritional status. Am J Clin Nutr, 34, 2540-2545, 1981.
12. Gonzalez MC, Duarte RRP, and Budziareck MB: Adductor pollicis muscle: Reference values of its thickness in a healthy population. Clin Nutr 30, 1-4, 2009.
13. Barbosa-Silva MC, Barros AJ, and Larsson E: Phase angle reference values for Brazilian population. Int J Body Compos Res 6, 67-68, 2008.
14. Budziareck MB, Duarte RRP, and Barbosa-Silva MCG: Reference values and determinants for handgrip strength in healthy subjects. Clin Nutr 27, 357-362, 2008.
15. Scott HR, Mcmillan DC, Forrest LM, Brown DJ, Mcardle CS, et al.: The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87, 264-267, 2002.
16. Slaviero KA, Read JA, Clarke SJ, and Rivory LP: Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 46, 148-157, 2003.
17. Read JA, Choy ST, Beale PJ, and Clarke SJ: Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival, Nutr Cancer 55, 78-85, 2006.
18. Deans DAC, Tan BH, Wigmore SJ, Ross JA, Beaux AC, et al.: The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal câncer. Br J Cancer 100, 63-69, 2009.
19. Omran ML and Morley JE: Assessment of protein energy malnutrition in older persons: Part II. Laboratory evaluation. Nutr 16, 131-140, 2000.
20. Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, et al.: Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 92, 957-962, 2004.
21. Forrest LM, Mcmillan DC, Mcardle CS, Angerson WJ, and Dunlop DJ: Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patient receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90, 1704-1706, 2004.
22. Crumley ABC, Mcmillan DC, Mckernan M, Mcdonald AC, and Stuart RC: Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-esophageal cancer. Br J Cancer 94, 637-641, 2006.
23. Murri AM, Bartlett JMS, Canney PA, Doughty JC, Wilson C, et al.: Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94, 227-230, 2006.
24. Mcmillan DC, Crozier JEM, Canna K, Angerson WJ, and Mcardle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22, 881-886, 2007.